Literature DB >> 3498163

B-cell-stimulatory factor 1 reverses Fc receptor-mediated inhibition of B-lymphocyte activation.

A O'Garra, K P Rigley, M Holman, J B McLaughlin, G G Klaus.   

Abstract

Intact (IgG class) rabbit anti-immunoglobulin antibodies are not mitogenic for mouse B cells but inhibit proliferation induced by F(ab')2 anti-Fab fragment antibodies (anti-Ig). In addition, cross-linkage of Fc and surface immunoglobulin receptors on B cells by intact anti-Ig inhibits inositol phospholipid breakdown (but not Ca2+ flux) resulting from ligation of antigen receptors. This system, therefore, provides a polyclonal model for B-cell inactivation by antigen-antibody complexes. T-cell-derived B-cell-stimulatory factor 1 acts synergistically with submitogenic concentrations of F(ab')2 anti-Ig to induce B-cell proliferation. We show here that B-cell-stimulatory factor 1 and intact anti-Ig also induce B cells to synthesize DNA. However, B-cell-stimulatory factor 1 does not induce inositol phospholipid breakdown, does not mobilize Ca2+ in B cells, nor does it influence the magnitude of these responses provoked by intact anti-Ig.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3498163      PMCID: PMC299049          DOI: 10.1073/pnas.84.17.6254

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  33 in total

1.  Cross-linking of B lymphocyte Fc gamma receptors and membrane immunoglobulin inhibits anti-immunoglobulin-induced blastogenesis.

Authors:  N E Phillips; D C Parker
Journal:  J Immunol       Date:  1984-02       Impact factor: 5.422

2.  The use of haptenated immunoglobulins to induce B cell tolerance in vitro. The roles of hapten density and the Fc portion of the immunoglobulin carrier.

Authors:  T J Waldschmidt; Y Borel; E S Vitetta
Journal:  J Immunol       Date:  1983-11       Impact factor: 5.422

3.  Fc-dependent inhibition of mouse B cell activation by whole anti-mu antibodies.

Authors:  N E Phillips; D C Parker
Journal:  J Immunol       Date:  1983-02       Impact factor: 5.422

4.  Partial purification and characterization of a BCGFII from EL4 culture supernatants.

Authors:  R W Dutton; G D Wetzel; S L Swain
Journal:  J Immunol       Date:  1984-05       Impact factor: 5.422

5.  Identification of a T cell-derived b cell growth factor distinct from interleukin 2.

Authors:  M Howard; J Farrar; M Hilfiker; B Johnson; K Takatsu; T Hamaoka; W E Paul
Journal:  J Exp Med       Date:  1982-03-01       Impact factor: 14.307

Review 6.  The Fc-receptor: its role in the transmission of differentiation signals.

Authors:  E Kölsch; J Oberbarnscheidt; K Brüner; J Heuer
Journal:  Immunol Rev       Date:  1980       Impact factor: 12.988

Review 7.  Induction and suppression of polyclonal antibody responses by anti-Ig reagents and antigen-nonspecific helper factors: a comparison of the effects of anti-Fab, anti-IgM, and anti IgD on murine B cells.

Authors:  D C Parker
Journal:  Immunol Rev       Date:  1980       Impact factor: 12.988

8.  Activation and proliferation signals in mouse B cells. I. A comparison of the capacity of anti-Ig antibodies or phorbol myristic acetate to activate B cells from CBA/N or normal mice into G1.

Authors:  C M Hawrylowicz; K D Keeler; G G Klaus
Journal:  Eur J Immunol       Date:  1984-03       Impact factor: 5.532

9.  Relationship between cell ploidy and glucocorticoid induced death in human lymphoid cell lines.

Authors:  J E Dyson; P Quirke; C C Bird; J B McLaughlin; C R Surrey
Journal:  Br J Cancer       Date:  1984-06       Impact factor: 7.640

10.  Interleukin-induced increase in Ia expression by normal mouse B cells.

Authors:  N W Roehm; H J Leibson; A Zlotnik; J Kappler; P Marrack; J C Cambier
Journal:  J Exp Med       Date:  1984-09-01       Impact factor: 14.307

View more
  9 in total

Review 1.  Feedback regulation of antibody production: a role in rheumatoid arthritis?

Authors:  J K Kalsi; N D Hall
Journal:  Ann Rheum Dis       Date:  1991-11       Impact factor: 19.103

2.  A major myristylated substrate of protein kinase C and protein kinase C itself are differentially regulated during murine B- and T-lymphocyte development and activation.

Authors:  P Hornbeck; H Nakabayashi; B J Fowlkes; W E Paul; D Kligman
Journal:  Mol Cell Biol       Date:  1989-09       Impact factor: 4.272

3.  Gene mapping of mouse IL-4 receptor: the loci of interleukin 4 (IL-4) receptor gene and lymphocyte function associated antigen 1 (LFA-1) gene are closely linked on chromosome 7.

Authors:  H Suzuki; F Z Chung; E Palmer; T Sasaki; N Ohara; B A Taylor; J Ohara
Journal:  Immunogenetics       Date:  1991       Impact factor: 2.846

Review 4.  Cellular signalling mechanisms in B lymphocytes.

Authors:  W Cushley; M M Harnett
Journal:  Biochem J       Date:  1993-06-01       Impact factor: 3.857

Review 5.  The immunomodulatory effects of interferon-gamma on mature B-lymphocyte responses.

Authors:  A Jurado; J Carballido; H Griffel; H K Hochkeppel; G D Wetzel
Journal:  Experientia       Date:  1989-06-15

6.  Lipopolysaccharide-induced IgM production is not suppressed by antigen receptor ligation in B cells from some autoimmune strains of mice.

Authors:  C C Anderson; R Rahimpour; N R Sinclair
Journal:  Immunol Res       Date:  1994       Impact factor: 2.829

7.  A transmembrane polymorphism in FcgammaRIIb (FCGR2B) is associated with the production of anti-cyclic citrullinated peptide autoantibodies in Taiwanese RA.

Authors:  J-Y Chen; C-M Wang; C-C Ma; L-A Hsu; H-H Ho; Y-J J Wu; S-N Kuo; J Wu
Journal:  Genes Immun       Date:  2008-07-17       Impact factor: 2.676

8.  Interleukin 4 reduces expression of inhibitory receptors on B cells and abolishes CD22 and Fc gamma RII-mediated B cell suppression.

Authors:  Elizabeth U Rudge; Antony J Cutler; Nicholas R Pritchard; Kenneth G C Smith
Journal:  J Exp Med       Date:  2002-04-15       Impact factor: 14.307

9.  Distinct cell-specific control of autoimmunity and infection by FcgammaRIIb.

Authors:  Rebecca J Brownlie; Kate E Lawlor; Heather A Niederer; Antony J Cutler; Zou Xiang; Menna R Clatworthy; R Andres Floto; David R Greaves; Paul A Lyons; Kenneth G C Smith
Journal:  J Exp Med       Date:  2008-03-24       Impact factor: 14.307

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.